Abstract
The ethical use of animals in biomedical research has been shaped by the guiding framework of the 3Rs-Replacement, Reduction and Refinement. With rapid advancements in biotechnology, computational sciences and translational medicine, the practical integration of these principles has evolved beyond regulatory compliance toward innovation-driven ethical research. This review examines emerging multidisciplinary strategies that operationalize the 3Rs across modern biomedical research pipelines. Replacement approaches increasingly employ human-relevant alternatives such as advanced in vitro models, organ-on-chip platforms, computational simulations, and artificial intelligence-assisted predictive models, reducing reliance on traditional animal experimentation. Reduction strategies emphasize rigorous experimental design, improved statistical methodologies, data-sharing initiatives, and high-resolution imaging technologies that maximize data output while minimizing animal use. Refinement focuses on improving animal welfare through enhanced housing conditions, minimally invasive monitoring technologies, precision analgesia and welfare-based humane endpoints. The integration of these principles is strengthened by collaboration among biologists, veterinarians, engineers, bioinformaticians, and ethicists. Furthermore, regulatory frameworks and funding agencies increasingly promote the adoption of innovative alternative methodologies aligned with the 3Rs. By embedding ethical responsibility within scientific practice, the multidisciplinary implementation of the 3Rs contributes to improved research reproducibility, enhanced translational relevance and greater societal acceptance of biomedical research. Ultimately, advancing ethical innovations in research design supports the transition toward more predictive, human-relevant models while maintaining high standards of animal welfare.
References
[1] Frühwein H, Paul NW. “Lost in translation?” Animal research in the era of precision medicine. J Transl Med 2025;23:152. https://doi.org/10.1186/s12967-025-06084-3.
[2] Hernández López JR. Bioethics in the Use of Laboratory Animals, Strategies for Reduction, Replacement, and Refinement in rodents. Mexican Journal of Medical Research ICSA 2026;14:29–34. https://doi.org/10.29057/mjmr.v14i27.14572.
[3] Verma A, Shrivastava A. Animal Model Replacement Using AI Simulation: An Expanding Frontier in Biomedical Research. International Journal of Newgen Research in Pharmacy & Healthcare 2025:158–63. https://doi.org/10.61554/ijnrph.v3i2.2025.195.
[4] Gangwal A, Lavecchia A. Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing. Drug Discov Today 2025;30:104360. https://doi.org/10.1016/j.drudis.2025.104360.
[5] Pavlović E, Dutta S, Garssen J, Folkerts G. Beyond the cage: The rise and promise of non-animal models in biomedical research. Eur J Pharmacol 2026;1019:178686. https://doi.org/10.1016/j.ejphar.2026.178686.
[6] Storz MA, Dean E. Status of animal experimentation in nutrition and dietetic research: Policies of 100 leading journals and new approach methodologies. Account Res 2025;32:1545–63. https://doi.org/10.1080/08989621.2024.2398104.
[7] Azkona G. 3Rs (replacement, reduction, and refinement) alternatives. Sustainability in the Manufacturing of Pharmaceuticals, Elsevier; 2025, p. 281–309. https://doi.org/10.1016/B978-0-443-28921-7.00003-8.
[8] Domínguez-Oliva A, Hernández-Ávalos I, Martínez-Burnes J, Olmos-Hernández A, Verduzco-Mendoza A, Mota-Rojas D. The Importance of Animal Models in Biomedical Research: Current Insights and Applications. Animals 2023;13:1223. https://doi.org/10.3390/ani13071223.
[9] Kumar D, Gupta S, Gupta V, Tanwar R, Chandel A. Engineering the Future of Regenerative Medicines in Gut Health with Stem Cell-Derived Intestinal Organoids. Stem Cell Rev Rep 2025;21:1449–70. https://doi.org/10.1007/s12015-025-10893-w.
[10] Moresis A, Restivo L, Bromilow S, Flik G, Rosati G, Scorrano F, et al. A minimal metadata set (MNMS) to repurpose nonclinical in vivo data for biomedical research. Lab Anim (NY) 2024;53:67–79. https://doi.org/10.1038/s41684-024-01335-0.
[11] Luce E, Duclos-Vallee J-C. Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine. Pharmaceuticals 2025;18:992. https://doi.org/10.3390/ph18070992.
[12] Zhang J, Li H, Zhang Y, Huang J, Ren L, Zhang C, et al. Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction. Brief Bioinform 2025;26. https://doi.org/10.1093/bib/bbaf533.
[13] Gangwal A, Lavecchia A. Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing. Drug Discov Today 2025;30:104360. https://doi.org/10.1016/j.drudis.2025.104360.
[14] Ahmed M, Othman R, Noordin MF, Ibrahim AA, Al-Hussaini AIS. Factors influencing open science participation through research data sharing and reuse among researchers: a systematic literature review. Knowl Inf Syst 2025;67:2801–53. https://doi.org/10.1007/s10115-024-02284-3.
[15] Xu J, Gao C, Zhang J, Lu J, Xuan Y, Wang S, et al. Advancements in Imaging Technologies and AI Integration for Neurodegenerative Disease Management: A Narrative Review. Mol Imaging 2025;24. https://doi.org/10.1177/15353508251393056.
[16] Diogo Gonçalves S, Rodrigues M, Avidos M, Morais AB, Caramelo A. Use of artificial intelligence in animal experimentation: A review. Toxicol Lett 2025;411:89-100. https://doi.org/10.1016/j.toxlet.2025.07.1417.
[17] Neethirajan S. Rethinking Poultry Welfare—Integrating Behavioral Science and Digital Innovations for Enhanced Animal Well-Being. Poultry 2025;4:20. https://doi.org/10.3390/poultry4020020.
[18] Iber BT, Sethi P, Saini R, Dhiman N, Madan A. Emerging Global Technologies in Veterinary Sciences. One Health Integration, Wiley; 2025, p. 227–56. https://doi.org/10.1002/9781394295982.ch08.
[19] Sandhu JS, Parida A, Hegde S, V. M. Artificial intelligence in biomedical research: advancing non-animal methodologies. Frontiers in Animal Science 2025;6. https://doi.org/10.3389/fanim.2025.1687111.
[20] Gollamudi S. Emerging Human-Based Alternative Technologies as Replacements for Preclinical Animal Testing. Prog Nucl Energy 6 Biol Sci 2025;05. https://doi.org/10.55006/biolsciences.2025.5402.
[21] Choudhary OP. Animal models for surgeries and implants: a vital tool in medical research and development. Annals of Medicine & Surgery 2025;87:4090–5. https://doi.org/10.1097/MS9.0000000000003400.
[22] Al-Kabani A, Huda B, Haddad J, Yousuf M, Bhurka F, Ajaz F, et al. Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology. Cancers (Basel) 2025;17:2163. https://doi.org/10.3390/cancers17132163.
[23] Marques L, Vale N. A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models. Pharmaceutics 2025;17:747. https://doi.org/10.3390/pharmaceutics17060747.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Frontiers in Preventive Medicine